February 2021 - Wellthy Therapeutics

Monthly Archives: February 2021

How to transform patient engagement with value based care using DigitalTherapeutics(DTx)?

Transforming patient engagement and value based care with DTx

The traditional fee-for-service model of healthcare is an inherently defective one because it leads to a conflict of interest between different stakeholders as it focuses on volume rather than quality of healthcare service. Many countries across the world are now slowly but steadily transitioning from this model to value-based care, where reimbursement to providers is contingent upon measurable clinical outcomes. As patients come centre stage in value-based care and providers become more accountable for the wellness of their patient populations, DTx shows promise by empowering patients. Digital therapeutics can thus be an effective tool for value-based care by leveraging the patient’s healthcare data to augment traditional clinical therapies with actionable intelligence provided to patients and physicians in real time for a more strategic and personalized care.

How an effective post-care strategy can reduce heart failure readmissions rates for patients?

Reducing heart failure readmissions with effective post-care strategy

One of the primary and most concerning health problems is declining heart conditions and what tops the list is Congestive Heart Failure. Irrespective of the underlying cause, heart failure (HF) generates an enormous clinical, societal and economic burden. Healthcare providers around the world are trying to improve and transform patient care and disease managemnet to help reduce the per capita cost of health care.